Biden’s visit to racist massacre site will highlight US divisions

Published by
AFP

Washington (AFP) – When President Joe Biden visits the site of a racist massacre in upstate New York on Tuesday, he’ll confront not only the shocking deaths of 10 Black people but a growing sense that extremism is pulling at the fabric of US society. On one level, the trip by Biden and his wife Jill Biden to Buffalo will be a grimly routine tradition for presidents who for decades have railed against an unstoppable parade of mass shootings. Like all his predecessors to varying degrees, Biden has promised to address gun control, or rather the lack of gun control. Like them, he has made barely a…

Read more

Lacking vaccines, N.Korea battles COVID with antibiotics, home remedies

Published by
Reuters

By SungHyuk An and Heejung Jung SEOUL (Reuters) – Standing tall in bright red hazmat suits, five North Korean health workers stride towards an ambulance to do battle with a COVID-19 outbreak that – in the presumed absence of vaccines – the country is using antibiotics and home remedies to treat. The isolated state is one of only two countries yet to begin a vaccination campaign and, until last week, had insisted it was COVID-free. Now it is mobilizing forces including the army and a public information campaign to combat what authorities have acknowledged is an “explosive” outbreak. In an inter…

Read more

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Paclitaxel and Cisplatin in First-Line Treatment of Advanced or Distant Metastatic Esophageal Squamous Cell Carcinoma

–5th approved indication by NMPA significantly expands eligible patient population SHANGHAI, China, May 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (NMPA) has […]

CPO Fintech Platform Topwatch Achieves Significant Milestones

Blockchain authentication enabled from Topwatch with ORIGYN Luxury partnership. Topwatch to exceed R 1 billion in revenue for 2022. Total accumulated Assets Under Management (AUM) exceeds R 3 billion ($202 m). Twelve year anniversary since first transaction in 2010. Every Watch has a story – Topwatch.com CAPE TOWN, South Africa, May 16, 2022 (GLOBE NEWSWIRE) […]

BluChip Launches an Innovative NFT Marketplace Uniquely Tethering the Value of Museum Artwork to NFTs

BluChip Pioneers the “Swappable” BluChip NFT Marketplace logo PALM SPRINGS, Calif., May 16, 2022 (GLOBE NEWSWIRE) — BluChip today introduced its unique platform enabling the purchase of non-fungible tokens (NFTs) that are tethered to an original fine art painting or sculpture. With this ability, NFTs now have actual physical value specific to world-class artwork, making them more […]

Crowdz Secures $10M Strategic Investment, Led by Citi and Global Cleantech Capital

The investment will enable Crowdz to expand its ability to bring accessible working capital to small businesses. Crowdz Blockchain Technology CAMPBELL, Calif., May 16, 2022 (GLOBE NEWSWIRE) — Small and mid-sized enterprise (SME) finance platform Crowdz has secured $10 million in investment, led by Citi and Global Cleantech Capital, with participation from Bold Capital Partners, […]

Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessment Reduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injury Ultra-low contrast PCI procedures […]